MED13L haploinsufficiency syndrome has been described in two patients and is characterized by moderate intellectual disability (ID), conotruncal heart defects, facial abnormalities and hypotonia. Missense mutations in MED13L are linked to transposition of the great arteries and non-syndromal intellectual disability. Here we describe two novel patients with de novo MED13L aberrations. The first patient has a de novo mutation in the splice acceptor site of exon 5 of MED13L. cDNA analysis showed this mutation results in an in-frame deletion, removing 15 amino acids in middle of the conserved MED13L N-terminal domain. The second patient carries a de novo deletion of exons 6-20 of MED13L. Both patients show features of the MED13L haploinsufficiency syndrome, except for the heart defects, thus further confirming the existence of the MED13L haploinsufficiency syndrome. MED13L was found to map to the breakpoints of a patient with intellectual disability (ID) and transposition of the great arteries. Subsequent sequencing of the gene in a larger cohort of patients with transposition of the great arteries identified three additional missense mutations in MED13L. 2 A large resequencing study of homozygous regions in consanguineous patients identified a homozygous missense variant in MED13L as a cause of nonsyndromic ID. 3 Asadollahi et al 4 presented two patients with MED13L haploinsufficiency. These patients suffered from a similar phenotype of hypotonia, moderate ID, conotruncal heart defects and specific dysmorphic facial features, including macroglossia. Their findings showed that MED13L haploinsufficiency in contrast to the previously observed missense mutations cause a distinct syndromic phenotype.Here, we describe two new patients with de novo MED13L aberrations who are phenotypically similar to the patients described by Asadollahi et al 4 but lack the cardiac phenotype.